Apogee Therapeutics
APGE
APGE
157 hedge funds and large institutions have $2.62B invested in Apogee Therapeutics in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 55 increasing their positions, 40 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $3.29B → $2.62B (-$671M)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
49% less call options, than puts
Call options by funds: $1.67M | Put options by funds: $3.29M
Holders
157
Holding in Top 10
4
Calls
$1.67M
Puts
$3.29M
Top Buyers
| 1 | +$33.9M | |
| 2 | +$32.6M | |
| 3 | +$30.2M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$26.4M |
| 5 |
JFG
Jefferies Financial Group
New York
|
+$23.5M |
Top Sellers
| 1 | -$58.7M | |
| 2 | -$43.8M | |
| 3 | -$22.3M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$18.3M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$17.8M |